Taking Advantage of the Systemic Immune System to Cure Brain Diseases

Slides:



Advertisements
Similar presentations
Microglia are tissue-resident macrophages in the CNS.
Advertisements

CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma  André Veillette, Huaijian Guo  Critical Reviews.
Stem Cells for Spinal Cord Repair
Alzheimer’s Disease Genetics: From the Bench to the Clinic
Aleksandra Deczkowska, Michal Schwartz  Immunity 
Gut Microbiota: A Natural Adjuvant for Vaccination
Athena Kalyvas, Samuel David  Neuron 
Alan N. Houghton, Hiroshi Uchi, Jedd D. Wolchok  Cancer Cell 
Vaccine Adjuvants: Putting Innate Immunity to Work
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Testing the Amyloid Hypothesis with a Humanized AD Mouse Model
Julius A. Steinbeck, Lorenz Studer  Neuron 
Upgrading from iMac to iMicro
Volume 60, Issue 3, Pages (November 2008)
Bettina Schreiner, Melanie Greter  Cell Stem Cell 
Using Epigenetic Reprogramming to Treat Pediatric Brain Cancer
Alzheimer’s Disease Genetics: From the Bench to the Clinic
David J. Nikolic-Paterson, Shuang Wang, Hui Yao Lan 
Microglia Current Biology
Volume 32, Issue 3, Pages (March 2010)
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Radiation resistance and stem-like cells in brain tumors
Volume 49, Issue 1, Pages 4-8 (January 2006)
CNS Injury: IL-33 Sounds the Alarm
Mieke Aldenhoven, JaapJan Boelens, Tom J. de Koning 
Detection of bone marrow–derived lung epithelial cells
Volume 59, Issue 4, Pages (August 2008)
Treating Obesity? It's in the Bag!
Origin and Functions of Tissue Macrophages
Amyloid Cascade into Clarity
Volume 18, Issue 2, Pages (February 2016)
Healing Genes in the Nervous System
Development of Dendritic-Cell Lineages
Volume 64, Issue 1, Pages (October 2009)
Immune Modulation of Stem Cells and Regeneration
The Role of Apolipoprotein E in Alzheimer's Disease
A Developmental Switch in Microglial HDAC Function
Volume 5, Issue 3, Pages (November 2013)
I Remember You: Epigenetic Priming in Epithelial Stem Cells
Volume 85, Issue 4, Pages (February 2015)
Estrogen Receptor Transrepresses Brain Inflammation
Myeloid Cells in the Central Nervous System
Indiscriminate Memories during Infection Control
Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice  Mohammad A.
T Cell Cosignaling Molecules in Transplantation
Tissue-Resident Macrophage Ontogeny and Homeostasis
Microglia: New Roles for the Synaptic Stripper
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Volume 31, Issue 5, Pages (November 2009)
Sublime Microglia: Expanding Roles for the Guardians of the CNS
Monocyte-Macrophages and T Cells in Atherosclerosis
Kurt M. Lucin, Tony Wyss-Coray  Neuron 
Current Challenges in Glia-Pain Biology
Microglia: Senescence Impairs Clearance of Myelin Debris
Sensors of Succinate: Neural Stem Cell Grafts Fight Neuroinflammation
Microglia: Multitasking Specialists of the Brain
Bettina Schreiner, Melanie Greter  Cell Stem Cell 
Volume 21, Issue 4, Pages (April 2013)
Herpes Simplex Virus Encephalitis: Toll-Free Access to the Brain
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Microglia: You’ll Never Walk Alone!
Stem Cells on Patrol Cell
Sachin P. Gadani, James T. Walsh, John R. Lukens, Jonathan Kipnis 
Volume 49, Issue 4, Pages (February 2006)
Taking a Toll Road to Better Vaccines
Radiation resistance and stem-like cells in brain tumors
by Gonghua Huang, Yanyan Wang, Peter Vogel, and Hongbo Chi
Microglia: You’ll Never Walk Alone!
Engraftment of Bone Marrow–derived Stem Cells to the Lung in a Model of Acute Respiratory Infection by Pseudomonas aeruginosa  Joanna Rejman, Carla Colombo,
Presentation transcript:

Taking Advantage of the Systemic Immune System to Cure Brain Diseases V. Wee Yong, Serge Rivest  Neuron  Volume 64, Issue 1, Pages 55-60 (October 2009) DOI: 10.1016/j.neuron.2009.09.035 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Microglial Cells Microglia are the resident immune cells of the brain, and they are constantly patrolling the cerebral microenvironment. As depicted by panel (A), they are present in the entire central nervous system (CNS), including the spinal cord. There are regions that are more populated than others, and the white matter generally contains less microglia than the grey matter. They are highly ramified cells, and their processes are very active and plastic even during nonpathological conditions. Although their exact origin still remains to be fully established, both macrophages and microglial cells derive from myeloid progenitors. There are subpopulations of microglial cells, each of which may have different origins, i.e., the primitive macrophages from the yolk sac and those newly differentiated from monocytes or their progenitors. Concrete evidence demonstrating the capacity of bone marrow stem cells (BMSCs) to populate the CNS and differentiate into microglial cells was obtained in chimeric mice transplanted with bone marrow cells expressing green fluorescent protein (GFP). With the use of this model, many researchers have found donor-derived cells in the brain of host animals, and BMSCs indeed have the ability to populate the CNS and differentiate into functional parenchymal microglia as well as perivascular microglia (C and E). It is important to mention that the origin and role of microglia in the adult brain still remain highly debated today. (A and G) Resting microglia (green cells, immunofluorescence using a primary antibody directed against iba1; blue nuclei, DAPI). (B, D, and F) Highly ramified microglia (red cell, immunofluorescence using a primary antibody directed against iba1). (C and E) Bone-marrow-derived microglia from chimeric mice transplanted with bone marrow stem cells expressing green fluorescent protein (green GFP cells). The confocal images of the microglia subtypes were taken by Paul Préfontaine. Neuron 2009 64, 55-60DOI: (10.1016/j.neuron.2009.09.035) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Systemic Immune Approaches to Clear Amyloid Beta in Alzheimer's Disease Activation of the systemic innate immune system and bone marrow cells may be a powerful approach to treat AD and eliminate Aβ from the CNS. This can be done by specific toll-like receptor (TLR) ligands and other adjuvants, M-CSF, and immunization against Aβ. Other immunotherapies that have been tested in mouse models of AD include a T cell-based vaccination with glatiramer acetate, a drug used in multiple sclerosis. Finally, the genetic engineering of bone marrow stem cells to upregulate genes encoding chemokine receptors (e.g., CCR2), TLRs, CD14, Aβ-degradating enzymes, and neurotrophic factors may be a new direction to improve recruitment and functionality of bone-marrow-derived microglia/macrophages (BMDMs) in the CNS and favor their polarization toward neuroprotection. Such systemic immunotherapies may also be applied to other CNS diseases, because toxic and extracellular proteins are becoming a common feature of many brain disorders. Neuron 2009 64, 55-60DOI: (10.1016/j.neuron.2009.09.035) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 Beneficial Inflammation Heals CNS Injury through Several Mechanisms Neuron 2009 64, 55-60DOI: (10.1016/j.neuron.2009.09.035) Copyright © 2009 Elsevier Inc. Terms and Conditions